Ebola Virus: Sensationalism, Science, and Human Rights

Journal of Infectious Diseases

Volumn 212, Issue , 2015, Pages S79-S83

  Bausch, Daniel G ^a,b   Clougherty, Marguerite M ^a,b  

^a TULANE UNIVERSITY   (United States)

^b Center for Global Health   (United States)

Author keywords

Ebola; human rights; Marburg; viral hemorrhagic fever

Indexed keywords

EBOLA VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BIOLOGICAL WARFARE; CLINICAL TRIAL (TOPIC); CORONAVIRUS INFECTION; DISEASE TRANSMISSION; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; EPIDEMIC; FILOVIRUS INFECTION; GLOVE; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; HUMAN RIGHTS; INFECTION RISK; INFLUENZA; MARBURG HEMORRHAGIC FEVER; NEEDLE; NONHUMAN; PANDEMIC; POLITICS; PRIORITY JOURNAL; PUBLIC HEALTH; RECYCLING; REVIEW; RISK FACTOR; SCIENCE; SEVERE ACUTE RESPIRATORY SYNDROME; SOCIOECONOMICS; TUBERCULOSIS; HEMORRHAGIC FEVER, EBOLA; IMMUNOLOGY; LEGISLATION AND JURISPRUDENCE;

DISEASE OUTBREAKS; EBOLA VACCINES; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMAN RIGHTS; HUMANS; RISK FACTORS;

EID: 84943259224     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv359     Document Type: Review

References (16)

1. Camara B. Maternity care at Guinea's largest government hospital. http://pulitzercenter.org/reporting/africa-guinea-maternal-healthinfant-mortality. Accessed 22 June 2015.
2. Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea-preliminary report. N Engl J Med 2014; 371:1418-25.
3. Bausch D, Rollin P. Responding to epidemics of Ebola hemorrhagic fever: progress and lessons learned from recent outbreaks in Uganda, Gabon, and Congo. Emerg Infect 2004; 6:35-57.
4. Shelton SR, Connor K, Uscher-Pines L, Pillemer FM, Mullikin JM, Kellermann AL. Bioterrorism and biological threats dominate federal health security research: other priorities get scant attention. Health Aff (Millwood) 2012; 31:2755-63.
5. Towner JS, Amman BR, Sealy TK, et al. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog 2009; 5:e1000536.
6. Leroy EM, Kumulungui B, Pourrut X, et al. Fruit bats as reservoirs of Ebola virus. Nature 2005; 438:575-6.
7. Amman BR, Carroll SA, Reed ZD, et al. Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog 2012; 8:e1002877.
8. Cohen J. Infectious disease: Ebola vaccines racing forward at record pace. Science 2014; 345:1228-9.
9. Falzarano D, Geisbert TW, Feldmann H. Progress in filovirus vaccine development: evaluating the potential for clinical use. Expert Rev Vaccines 2011; 10:63-77.
10. Bausch D. Of sickness unknown: death, and health, in Africa. United Nations Chronicle 2001; 38:5-13.
11. Allan R, Mardell S, Ladbury R, Pearce E, Kathleen S. The progression from endemic to epidemic Lassa fever in war-torn West Africa. In: Saluzzo JF, Dodet B, eds. Factors in the emergence and control of rodent-borne viral diseases (hantaviral and arenal diseases). Paris, France: Elsevier; 1999:197-205.
12. Bertherat E, Talarmin A, Zeller H. Democratic Republic of the Congo: between civil war and the Marburg virus. International Committee of Technical and Scientific Coordination of the Durba Epidemic [in French]. Med Trop (Mars) 1999; 59:201-4.
13. Bausch DG, Schwarz L. Outbreak of Ebola virus disease in Guinea: where ecology meets economy. PLoS Negl Trop Dis 2014; 8:e3056.
14. United Nations Development Programme Human Development Index, 2013. http://hdr.undp.org/en/content/human-development-index-hditable. Accessed 13 July 2015.
15. United Nations. The Universal Declaration of Human Rights. UN General Assembly. New York, NY: United Nations, 1948.
16. Khan SH, Goba A, Chu M, et al. New opportunities for field research on the pathogenesis and treatment of Lassa fever. Antiviral Res 2008; 78:103-15.